background
broad
spectrum
pathogen
caus
respiratori
tract
infect
symptom
mostli
similar
therefor
identif
caus
virus
bacteria
feasibl
use
multiplex
pcr
sever
monoplex
pcr
test
parallel
method
analyt
sensit
three
multiplex
pcr
assay
xtagrespiratoryviruspanelfastassay
rvp
compar
monoplex
realtim
pcr
quantifi
standard
control
materi
assay
includ
common
respiratori
pathogen
result
compar
analyt
sensit
multiplex
assay
sampl
inocul
differ
quantifi
virus
rang
copiesml
concord
result
receiv
rhinoviru
wherea
rvp
detect
influenzaviru
rsv
hmpv
frequent
low
concentr
show
higher
analyt
sensit
adenovirus
coronavirus
wherea
rvp
incap
detect
adenoviru
coronaviru
concentr
copiesml
detect
influenzavirus
copiesml
rsv
copiesml
detect
virus
one
sampl
achiev
use
monoplex
pcr
analyz
possibl
competit
amplif
reaction
differ
virus
sampl
inocul
differ
virus
one
sampl
compar
detect
virus
parallel
differ
found
incid
respiratori
virus
compar
tracheal
secret
ts
sampl
n
mechan
ventil
patient
winter
n
summer
n
winter
respiratori
virus
detect
ts
sampl
wherea
detect
rate
rvp
frequent
virus
adenoviru
multipl
infect
detect
ts
sampl
fewer
infect
found
summer
rvp
posit
result
verifi
use
monoplex
pcr
conclus
multiplex
pcr
test
broad
spectrum
pathogen
test
time
analysi
multipl
inocul
sampl
reveal
differ
focu
detect
viru
type
three
assay
analysi
clinic
sampl
show
high
concord
detect
virus
compar
monoplex
test
acut
respiratori
tract
infect
widespread
type
infect
adult
children
respons
consider
morbid
mortal
worldwid
high
rate
respiratori
tract
infect
caus
virus
approxim
within
last
ten
year
diagnosi
respiratori
virus
becom
import
unexpect
emer
howev
effici
pathogenbas
prophylaxi
therapi
signific
effect
diseas
progress
patient
overcom
limit
concern
use
sever
monoplex
test
parallel
result
shortag
sampl
volum
develop
multiplex
test
fast
exact
identif
necessari
today
sever
multiplex
test
commerci
avail
number
studi
alreadi
compar
detect
frequenc
multiplex
assay
convent
monoplexpcr
assay
clinic
sampl
comparison
analyt
sensit
multiplex
assay
quantifi
standard
control
materi
exist
studi
present
first
comparison
analyt
sensit
three
novel
multiplex
pcr
method
assay
respifindersmart
singl
tube
multiplex
amplif
realtim
assay
pathofind
maastricht
netherland
xtag
respiratori
viru
panel
fast
assay
abbott
molecular
wiesbaden
germani
quantifi
viru
control
materi
assay
base
multiplex
ligationdepend
probe
amplif
analyz
capillari
electrophoresi
detect
respiratori
virus
bacteria
one
reaction
develop
assay
assay
also
base
multiplex
ligationdepend
probe
amplif
assay
differenti
respiratori
virus
bacteria
one
reaction
melt
curv
analysi
xtag
respiratori
viru
panel
fast
assay
rvp
bead
arraybas
system
detect
differ
respiratori
virus
previou
studi
clinic
sampl
show
sensit
specif
rvp
assay
respect
compar
realtim
pcrmethod
current
declar
gold
standard
anoth
studi
perform
comparison
clinic
sampl
precursor
assay
rvp
assay
studi
excel
specif
sensit
rvp
assay
respect
aim
present
studi
follow
quantif
commerci
avail
qualit
control
materi
b
evalu
perform
sensit
three
multiplex
assay
rvp
fast
assay
c
applic
perform
multiplex
pcr
assay
routin
set
furthermor
first
screen
studi
determin
incid
infect
respiratori
pathogen
mechan
ventil
patient
cohort
develop
atyp
pneumonia
postop
monitor
use
multiplex
pcr
assay
tracheal
secret
ts
sampl
n
collect
februari
winter
n
juli
summer
n
mechan
ventil
nonimmunocompromis
patient
male
femal
mean
age
year
rang
patient
suspect
atyp
pneumonia
postop
monitor
coronari
arteri
bypass
heart
lung
surgeri
ts
sampl
initi
analyz
bacteri
viral
pathogen
routin
diagnost
profil
includ
cmv
legionella
pneumophila
pneumocytisjirovecii
mycoplasma
pneumonia
chlamydophilapneumonia
residu
materi
use
compar
analysi
rvp
assay
result
perform
evalu
receiv
retrospect
influenc
patient
therapi
patient
provid
inform
consent
studi
need
ethic
approv
paragraph
german
act
medic
devic
german
gesetzuebermedizinprodukt
mpg
ethic
approv
requir
clinic
specimen
without
separ
invas
sampl
qualit
respiratori
valid
panel
global
zeptometrix
corpor
buffalo
new
york
quantifi
realtim
qpcr
extern
plasmid
standard
use
determin
concentr
differ
virus
plasmid
standard
adenoviru
posit
access
number
influenza
viru
posit
access
number
rsva
posit
access
number
enteroviru
posit
access
number
rhinoviru
posit
access
number
establish
sampl
analyz
triplic
three
independ
pcr
assay
virus
hmpv
quantifi
lightmix
assay
tib
molbiol
berlin
germani
viru
control
purifi
intact
viru
particl
chemic
modifi
render
noninfecti
refriger
stabl
quantif
virus
includ
panel
follow
influenza
viru
copiesml
copiesml
rsva
copiesml
adenoviru
copiesml
rhinoviru
copiesml
hmpv
copiesml
copi
ml
copiesml
copiesml
tabl
undilut
sampl
virus
viru
mix
total
volum
accordingli
undilut
sampl
inocul
virus
viru
mix
fill
pb
achiev
also
final
volum
subsequ
sampl
extract
use
nuclisenseasymag
autom
system
elut
volum
total
nucleic
acid
inocul
sampl
tracheal
secret
sampl
ts
extract
use
nuclisenseasymag
autom
system
germani
accord
manufactur
instruct
nucleic
acid
extract
ts
sampl
inocul
sampl
elut
final
volum
routin
diagnost
elut
buffer
respect
germani
manufactur
assay
pathofind
recommend
elut
volum
wherea
manufactur
rvp
assay
recommend
elut
volum
avoid
fals
neg
result
due
deviat
manufactur
instruct
extract
residu
materi
use
elut
volum
nucleic
acid
extract
test
use
rvp
assay
abbott
molecular
wiesbaden
germani
accord
manufactur
instruct
rvp
employ
multiplex
pcr
label
primer
singlestep
hybrid
pcr
product
fluoresc
bead
array
detect
perform
use
xmap
instrument
luminex
molecular
diagnost
inc
toronto
canada
analysi
perform
use
tda
rvp
fast
softwar
version
abbott
molecular
rvp
simultan
detect
influenza
viru
subtyp
influenza
b
viru
rsva
b
adenoviru
hmpv
coronavirus
picornaviru
enteroviru
rhinoviru
human
bocaviru
assay
also
includ
intern
posit
control
ad
specimen
extract
step
phage
posit
run
control
ad
plate
phage
lambda
dna
pathofind
maastricht
netherland
use
accord
manufactur
instruct
except
nucleic
acid
extract
patient
sampl
use
ts
sampl
instead
recommend
elut
volum
use
describ
previous
briefli
assay
compris
preamplif
step
combin
revers
transcriptas
multiplex
target
amplif
pcr
follow
probe
hybrid
step
probe
ligat
step
probe
amplif
step
analyz
amplifi
pcr
product
capillari
electrophoresi
use
dna
analyz
abi
appli
biosystem
darmstadt
germani
wherea
analyz
melt
curv
analysi
rotorgen
q
qiagen
hilden
germani
simultan
detect
respiratori
virus
adenoviru
coronavirus
hmpv
influenza
viru
influenza
viru
influenza
b
viru
rsva
b
rhinoviru
four
bacteria
bordetella
pertussi
chlamydophila
pneumonia
legionella
pneumophila
mycoplasma
pneumonia
addit
detect
coronaviru
enteroviru
bocaviru
assay
also
test
intern
posit
control
ad
specimen
extract
stage
rna
transcript
polyprotein
gene
encephalomyocard
viru
pcr
primer
probe
adapt
previous
describ
adenoviru
coronaviru
type
cytomegaloviru
cmv
enteroviru
influenza
viru
rsva
rhinoviru
legionella
pneumophila
bacteriophag
use
intern
control
ic
revers
transcript
pcr
previous
describ
bp
fragment
bacteriophag
lambda
posit
access
number
use
ic
avoid
competit
coamplif
dna
virus
rna
amplif
coronaviru
type
influenza
viru
rsva
rhinoviru
carri
ml
tube
contain
reaction
mix
rna
extract
reaction
mix
consist
invitrogen
rnxreaction
mix
includ
mm
mgso
nm
target
primer
nm
target
probe
nm
ic
primer
nm
ic
probe
u
invitrogen
superscript
platinum
taqenzym
mix
superscript
iii
onestep
rtpcr
platinumtaq
invitrogen
darmstadt
germani
pcr
product
bacteriophag
replicas
gene
ad
reaction
mixtur
exogen
ic
pcr
perform
rotorgen
q
system
qiagen
hilden
germani
revers
transcript
min
preliminari
denatur
min
follow
cycl
denatur
anneal
extens
singl
fluoresc
acquisit
step
end
anneal
step
dna
amplif
cmv
adenoviru
enteroviru
carri
ml
tube
contain
reaction
mix
dna
extract
reaction
mix
consist
taq
buffer
includ
mm
mg
nm
deoxynucleosid
triphosph
nm
target
primer
nm
target
probe
nm
ic
primer
nm
ic
probe
u
uracildna
glycosylas
ung
roch
diagnost
mannheim
germani
u
taq
dna
polymeras
prime
hamburg
germani
pcr
perform
rotorgen
system
corbett
life
scienc
sydney
australia
ung
activ
step
min
preliminari
denatur
min
follow
cycl
denatur
anneal
extens
singl
fluoresc
acquisit
step
end
anneal
step
legionella
pneumophila
pcr
carri
glass
capillari
contain
reaction
mix
dna
extract
reaction
mix
consist
faststart
dna
master
plu
hybrid
probe
roch
diagnost
mannheim
germani
nm
target
primer
nm
target
probe
nm
ic
primer
lambda
nm
ic
probe
u
ung
roch
diagnost
mannheim
germani
pcr
perform
lightcycl
system
roch
diagnost
mannheim
germani
ung
activ
step
min
preliminari
denatur
min
follow
cycl
denatur
anneal
extens
singl
fluoresc
acquisit
step
end
anneal
step
follow
melt
analysi
realtim
pcr
hmpv
perform
use
lightmix
assay
tib
molbiol
berlin
germani
lightcycl
system
accord
manufactur
instruct
cutoff
valu
decis
positiveneg
adjust
cycl
specif
monoplexrealtim
pcr
assay
determin
exclus
crossamplif
differ
bacteri
viral
dnasrna
eight
bacteria
seven
virus
analyt
sensit
determin
copi
ml
reproduc
assay
demonstr
analyz
interassay
variat
cross
threshold
ct
valu
determin
six
independ
pcr
run
key
paramet
realtim
pcr
assay
shown
tabl
viru
control
materi
zeptometrix
quantifi
extern
plasmid
standard
comparison
analyt
sensit
rvp
assay
subsequ
pbsbuffer
inocul
differ
quantifi
virus
virus
differ
combin
rang
copiesml
nucleic
acid
extract
analyz
parallel
three
multiplex
method
monoplex
realtim
pcr
method
elut
volum
rvp
show
detect
influenzaviru
infa
copiesml
respiratori
syntic
viru
b
rsvab
copiesml
coronaviru
cov
human
metapneumoviru
hmpv
copiesml
even
high
dilut
ratio
tabl
rhinoviru
hrv
also
detect
low
concentr
rvp
howev
assay
abl
differenti
human
rhinoviru
enteroviru
due
high
sequenc
similar
manufactur
inform
infb
cov
parainfluenzaviru
adenoviru
adv
detect
contrast
detect
adv
cov
also
low
concentr
eg
adv
howev
assay
detect
infa
b
rsva
b
well
hmpv
concentr
rang
copiesml
detect
concentr
copiesml
none
three
multiplex
assay
capabl
detect
virus
parallel
achiev
use
monoplex
realtim
pcr
assay
ct
valu
shown
tabl
order
simul
clinicalrelev
multipl
infect
well
analys
possibl
competit
amplif
reaction
differ
virus
pbsbuffer
inocul
differ
virus
one
assay
tabl
tabl
differ
found
use
elut
volum
rsva
adv
detect
assay
concentr
rang
copiesml
panel
copiesml
rsv
panel
adv
panel
rvp
assay
detect
adv
copiesml
panel
copiesml
panel
copiesml
panel
rvp
still
incap
detect
cov
howev
differ
found
detect
pathogen
use
differ
elut
volum
respifind
assay
compani
pathofind
suggest
elut
volum
assay
wherea
abbott
molecular
advis
rvp
assay
elut
volum
two
assay
compani
pathofind
detect
infa
sampl
extract
elut
buffer
detect
possibl
use
advis
extract
volum
detect
infa
concentr
copiesml
panel
wherea
assay
detect
infa
concentr
rang
copiesml
panel
observ
made
detect
adv
concentr
copi
ml
panel
use
advis
extract
volum
contrast
detect
frequenc
rsva
viru
reduc
respifind
assay
analys
sampl
elut
volum
compar
elut
volum
panel
undilut
sampl
panel
sampl
dilut
differ
detect
frequenc
found
rvp
assay
tabl
addit
evalu
applic
rvp
routin
diagnosi
distribut
virus
patient
cohort
ts
sampl
winter
februari
summer
juli
develop
particip
studi
start
commerci
avail
posit
result
verifi
realtim
pcr
monoplex
analysi
ts
sampl
obtain
routin
mechan
ventil
patient
coronari
arteri
bypass
heart
lung
surgeri
suspect
atyp
pneumonia
postop
monitor
respiratori
virus
detect
ts
sampl
winter
figur
frequent
virus
adv
found
ts
sampl
found
ts
sampl
detect
virus
cov
hrv
infb
rsva
infa
hmpv
comparison
rvp
detect
respiratori
virus
ts
sampl
rhinoviru
found
ts
sampl
frequent
viru
addit
cov
cov
adv
rsva
hmpv
summer
fewer
figur
comparison
rvp
realtim
pcr
result
ts
sampl
winter
summer
rectangular
box
symbol
differ
assay
l
pneumophila
spectrum
pathogen
rvp
cov
spectrum
respiratori
viru
infect
found
ts
sampl
differ
assay
detect
ts
sampl
respiratori
virus
contrast
rvp
found
virus
ts
sampl
respect
figur
furthermor
spectrum
detect
virus
smaller
summer
adv
hrv
addit
l
pneumophila
detect
order
confirm
posit
result
obtain
rvp
respifind
sampl
addit
test
monoplex
realtim
pcr
concord
figur
analys
three
ts
sampl
rvp
fail
tabl
error
messag
sampl
failur
salin
due
unexpect
control
call
appear
manufactur
provid
inform
possibl
sampl
posit
pathogen
spectrum
pathogen
kit
three
case
sampl
contain
cmv
detect
monoplex
realtim
order
exclud
cmv
pneumonia
due
reactiv
process
sampl
alreadi
test
cmv
line
standard
diagnost
profil
data
provid
complet
ts
sampl
februari
multipl
infect
detect
tabl
one
tripl
infect
infb
cmv
found
doubl
infect
adenoviru
well
adenoviru
cmv
frequent
combin
juli
doubl
infect
detect
ts
sampl
detect
multipl
infect
possibl
highest
detect
rate
virus
sampl
reach
confirm
reaction
perform
monoplex
pcr
assay
found
total
virus
ts
sampl
virus
detect
show
high
cycl
threshold
point
monoplex
pcr
method
due
low
viru
concentr
detect
respiratori
virus
multiplex
pcr
describ
import
tool
identif
pathogen
respiratori
tract
infect
today
comparison
three
multiplex
pcr
method
quantifi
standard
viru
control
materi
perform
therefor
quantifi
viru
control
materi
compar
analyt
sensit
three
commerci
avail
multiplex
pcr
method
follow
evalu
applic
routin
diagnosi
regard
handsontim
timetoresult
cost
accomplish
tabl
observ
rvp
assay
differ
focu
detect
viru
type
inocul
sampl
rvp
show
advanc
detect
infa
rsv
hmpv
wherea
show
improv
detect
cov
adv
show
improv
detect
virus
detect
also
low
concentr
copiesml
cov
hrv
detect
equal
also
low
concentr
three
assay
wherea
detect
parallel
analysi
monoplex
realtim
pcr
assay
show
expect
highest
analyt
sensit
virus
detect
concentr
dilut
factor
result
indic
possibl
competit
nucleotid
primer
enzym
differ
virus
detect
high
number
multipl
infect
virus
one
assay
virus
one
sampl
maximum
demand
multiplex
pcr
test
highli
artifici
experi
emphas
gener
methodolog
limit
multiplex
pcr
assay
nearli
multiplex
assay
perform
terribl
analyz
sampl
high
number
parallel
pathogen
therefor
result
interpret
attent
routin
clinic
set
parallel
infect
high
number
differ
virus
uncommon
imposs
clinic
relev
result
initi
arguabl
highest
viru
load
patient
cohort
tripl
infect
also
observ
research
group
due
fact
test
three
differ
combin
quadrupl
infect
surprisingli
differ
found
compar
highli
artifici
experi
virus
potenti
competit
reaction
found
detect
rsv
adv
respifind
infa
adv
rvp
howev
virus
still
detect
eg
rvp
cov
respifind
infa
observ
influenc
elut
volum
detect
elut
volum
show
tendenc
higher
analyt
sensit
howev
elut
volum
seem
differ
influenc
depend
contain
virus
exampl
infa
detect
frequent
elut
volum
wherea
rsv
show
higher
detect
frequenc
use
elut
volum
differ
found
detect
rvp
assay
although
expect
dilut
dnarna
extract
may
result
reduc
analyt
sensit
routin
test
use
differ
multiplex
assay
parallel
suggest
elut
volum
remain
extract
avail
retest
analysi
noninclud
pathogen
one
multiplex
assay
implement
elut
perform
accord
specif
manufactur
analysi
ts
sampl
done
parallel
rvp
time
commerci
avail
later
residu
extract
materi
avail
addit
test
comparison
three
multiplex
assay
clinic
sampl
studi
done
studi
indic
higher
clinic
sensit
detect
viru
infect
clinic
sampl
low
concentr
contrast
rvp
respiratori
tract
infect
found
ts
sampl
rvp
detect
sampl
respect
gadsbi
et
al
also
describ
problem
detect
low
viru
concentr
rvp
either
pathogen
detect
produc
falseposit
adenoviru
raymaek
et
al
investig
clinic
sampl
comparison
precursor
assay
rvp
xtag
respiratori
viral
panel
assay
abbott
molecular
wiesbaden
germani
precursor
assay
rvp
includ
target
specif
primer
extens
tspe
contrast
new
assay
therefor
result
directli
compar
present
studi
raymaek
studi
respiratori
virus
detect
rvp
clinic
sampl
result
compar
result
verifi
result
present
studi
comparison
precursor
assay
rvp
newer
rvp
assay
made
pabbaraju
et
al
show
older
assay
sensit
newer
rvp
fast
assay
sensit
respect
viral
target
combin
correspond
observ
concern
howev
higher
sensit
assay
may
also
due
detect
incident
noncaus
virus
februari
ts
sampl
assay
detect
multipl
infect
correspond
result
fox
wherea
rvp
assay
detect
multipl
infect
raymaek
et
al
also
describ
problem
detect
coinfect
tabl
patient
sampl
posit
pathogen
detect
winter
summer
rvp
sampl
includ
adenoviru
coronaviru
falseneg
rvp
observ
problem
sampl
posit
cmv
adenoviru
import
viral
coinfect
remain
uncertain
summari
detect
multipl
infect
ts
sampl
analyz
detect
multipl
infect
possibl
use
assay
howev
studi
also
demonstr
detect
multipl
infect
use
rvp
assay
context
question
aris
whether
detect
virus
multipl
infect
clinic
relev
case
pathogen
coinfect
caus
seriou
ill
eg
coronaviru
rsv
hmpv
pathogen
primari
infect
eg
rhinoviru
studi
approach
none
three
assay
differenti
pathogen
primari
infect
coinfect
viru
therefor
clinic
relev
addit
detect
virus
correl
studi
interpret
gener
data
three
assay
differ
level
difficulti
abbott
molecular
suppli
rvp
softwar
tool
tda
rvp
fast
softwar
analyz
gener
data
provid
automat
posit
neg
signal
detect
particular
viru
interpret
price
one
sampl
person
train
low
technician
familiar
sequenc
use
abi
system
result
difficult
manufactur
provid
help
data
analysi
eg
threshold
possibl
low
posit
sampl
miss
develop
improv
analysi
gener
data
given
melt
point
gener
comparison
spectrum
pathogen
detect
patient
cohort
mechan
ventil
patient
studi
eg
hardli
realiz
compar
limit
region
season
methodolog
differ
context
develop
respiratori
network
eg
wwwmedicaldpccomrespvir
allow
constant
comparison
season
accumul
chronolog
trend
applic
three
multiplex
pcr
method
routin
diagnost
set
handsontim
timetoresult
cost
accomplish
also
import
paramet
tabl
summar
specif
rvp
timetoresult
differ
three
half
hour
rvp
eight
hour
also
need
handsontim
step
rvp
develop
deliv
result
six
hour
amount
time
save
one
half
hour
signific
effect
diseas
progress
patient
respiratori
tract
infect
need
effici
pathogen
base
prophylaxi
therapi
multiplex
pcr
method
allow
fast
exact
identif
caus
pathogen
routin
applic
analyt
sensit
must
balanc
timetoresult
opinion
turnaroundtim
rvp
assay
signific
impact
patient
treatment
assay
provid
result
within
one
work
day
context
demand
strict
time
manag
achiev
result
within
day
studi
limit
unless
sampl
analyz
adequ
number
replic
perform
statist
analysi
approach
allow
comparison
perform
rang
sensit
three
multiplex
assay
analysi
inocul
sampl
quantifi
viru
materi
report
differ
may
due
chanc
regard
singl
consider
individu
result
howev
tendenc
toward
differ
lower
higher
detect
effici
differ
assay
observ
conclus
studi
show
multiplex
pcr
method
appli
routin
diagnost
balanc
analyt
sensit
timetoresult
handsontim
clinic
relev
detect
pathogen
higher
analyt
sensit
rvp
need
twice
long
result
compar
rvp
develop
provid
faster
result
test
routin
sampl
studi
